Delivery Order SPE2DB24D1205-SPE2DB25FCUYW

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,201.50 fixed-price delivery order is for the supply of Pirfenidone 267 mg tablets, a medication used to treat pulmonary fibrosis. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $102,116.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Pirfenidone 267 mg tablets, a medication used for the treatment of idiopathic pulmonary fibrosis. The contract has a completion date of February 13, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor...
This is a $9,892.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Pirfenidone 801 mg tablets, which are used to treat certain medical conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 90-count tablets of the drug Pirfenidone 801 mg to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,288.85 and a completion date of June 26, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $76,391.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562261053 - Pirfenidone 801 mg Tablets, 90 count, with a performance period through September 2023. The award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,246.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pirfenidone 801 mg tablets, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $50,015.94 firm-fixed-price delivery order is for the supply of 90-count tablets of Pirfenidone 801 mg. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 26, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,412.24 Firm Fixed Price Delivery Order is for the supply of pirfenidone 267 mg tablets, which are used to treat a respiratory condition. The contract has an ultimate completion date of April 9, 2024. While the original solicitation was not provided, the award appears to be part of a larger Indefinite Delivery...
This contract award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical is a Firm Fixed Price Delivery Order for the supply of 4,562,661,828 units of Pirfenidone 801 mg tablets. The contract has a ceiling value of $26,878.56 and a period of performance through November 1, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a comprehensive vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 270 tablets of the drug Pirfenidone 267 mg, with a ceiling value of $26,062.40 and a completion date of May 8, 2023. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen is a significant vendor for the...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCUYW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Pirfenidone 801 mg tablets, a medication used in the treatment of pulmonary fibrosis. The contract has a ceiling value of $8,769.25 and runs through March 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:48 AM